Interestingly, Chen et al., using a genetically-induced murine model for osteosarcoma, corresponding to targeted invalidations of p53 and Rb in the osteoblast lineage [22], have reported that total invalidation of RANKL in these mice completely blocked tumor development, despite inducing osteopetrosis. This evidence concerns the gene TNFSF11 and osteosarcoma.